Status:

COMPLETED

PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial)

Lead Sponsor:

Ontario Clinical Oncology Group (OCOG)

Collaborating Sponsors:

Ontario Ministry of Health and Long Term Care

Conditions:

Breast Cancer

Eligibility:

FEMALE

18+ years

Phase:

PHASE3

Brief Summary

The overall goal of this study is to determine how FDG-PET can be incorporated into the assessment of the axilla in the staging and treatment of women with early stage breast cancer. A multicentre, p...

Detailed Description

Patients will have histologic confirmation of invasive breast cancer and will have a FDG-PET scan prior to axillary node assessment. All patients will have a sentinel node biopsy if any sentinel nodes...

Eligibility Criteria

Inclusion

  • Histologic diagnosis of invasive breast cancer,
  • Resectable primary cancer.

Exclusion

  • The diagnosis of invasive breast cancer was made more than 3 months prior to registration,
  • Patient and/or surgeon are not willing to proceed with a SNB or AND after the PET scan is completed,
  • Patient and/or surgeon are not willing to proceed with a level I and II AND if the SNB is positive, if the PET scan shows increased uptake in the ipsilateral axilla, or if the surgeon is still gaining experience in the performance of SNB,
  • SNB or AND has already been done,
  • Chemotherapy has been given or will be given prior to PET scan or SNB or AND,
  • Significant serious concurrent medical problems (e.g., uncontrolled diabetes),
  • Patient is pregnant or lactating,
  • Patient is unable to lie supine and with both arms above their heads for PET scan,
  • Known hypersensitivity to FDG,
  • Clinical evidence of regional nodal metastases (fixed, matted axillary nodes),
  • Clinical evidence of distant metastases.

Key Trial Info

Start Date :

February 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2007

Estimated Enrollment :

336 Patients enrolled

Trial Details

Trial ID

NCT00201942

Start Date

February 1 2005

End Date

May 1 2007

Last Update

October 18 2007

Active Locations (10)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (10 locations)

1

St. Joseph's

Hamilton, Ontario, Canada, L8N 4A6

2

Juravinski Cancer Centre

Hamilton, Ontario, Canada, L8V 1C3

3

Kingston Regional Cancer Centre

Kingston, Ontario, Canada, K7L 5P9

4

London Regional Cancer Centre

London, Ontario, Canada, N6A 4L6

PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial) | DecenTrialz